TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04999059

Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue.”

The sponsor’s own words in the registry.

Life of this trial

201920202021202220232024Started2019-05-08Registered2021-08-04Stopped2023-08-16

Vital statistics

Status
Terminated
Sponsor
AVROBIO
Sponsor type
Industry
Conditions
Fabry Disease
Interventions
Safety and Efficacy Assessments
Participants
5
Sites
3
Countries
Australia, Brazil

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.